title: Re: Italian randomized trial among women with hysterectomy: tamoxifen and hormone-dependent breast cancer in high-risk women.
authors.forename: Sylvie
authors.initials: S
authors.lastname: Ménard
authors.forename: Patrizia
authors.initials: P
authors.lastname: Casalini
authors.forename: Elda
authors.initials: E
authors.lastname: Tagliabue
authors.forename: Serenella M
authors.initials: SM
authors.lastname: Pupa
authors.forename: Andrea
authors.initials: A
authors.lastname: Balsari
mesh_terms: D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000737:chemistry / Q000517:prevention & control*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007044:Hysterectomy; D007558:Italy / Q000453:epidemiology; D008403:Mass Screening; D009376:Neoplasms, Hormone-Dependent / Q000737:chemistry / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis*; D012307:Risk Factors; D013629:Tamoxifen / Q000627:therapeutic use*; D015854:Up-Regulation
chemical_list: D016588:Anticarcinogenic Agents; D018931:Antineoplastic Agents, Hormonal; D018719:Erb-b2 Receptor Tyrosine Kinases; D013629:Tamoxifen